Paola R. Lev

917 total citations
32 papers, 676 citations indexed

About

Paola R. Lev is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Paola R. Lev has authored 32 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 16 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Paola R. Lev's work include Platelet Disorders and Treatments (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Blood groups and transfusion (7 papers). Paola R. Lev is often cited by papers focused on Platelet Disorders and Treatments (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Blood groups and transfusion (7 papers). Paola R. Lev collaborates with scholars based in Argentina, United States and Italy. Paola R. Lev's co-authors include Rosana F. Marta, Paula G. Heller, Felisa C. Molinas, Nora P. Goette, Ana C. Glembotsky, Cecilia P. Marín Oyarzún, Beatriz Moiraghi, Giorgio Cattoretti, José M. Polo and Margaret A. Shipp and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Paola R. Lev

32 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paola R. Lev Argentina 15 375 280 209 143 117 32 676
Ana C. Glembotsky Argentina 17 552 1.5× 311 1.1× 164 0.8× 118 0.8× 100 0.9× 31 731
Gerlinde Mitterbauer‐Hohendanner Austria 10 327 0.9× 215 0.8× 88 0.4× 107 0.7× 156 1.3× 20 530
Carmelo Gurnari Italy 19 592 1.6× 324 1.2× 364 1.7× 208 1.5× 154 1.3× 141 1.0k
Jean Michel Cayuela France 10 481 1.3× 411 1.5× 132 0.6× 56 0.4× 245 2.1× 12 727
Serena Merante Italy 17 554 1.5× 492 1.8× 131 0.6× 89 0.6× 342 2.9× 40 828
Maria Kleppe United States 13 361 1.0× 302 1.1× 459 2.2× 233 1.6× 92 0.8× 24 947
Christina A. Ortmann Germany 9 467 1.2× 459 1.6× 347 1.7× 112 0.8× 138 1.2× 10 756
Nicolas Duployez France 17 621 1.7× 303 1.1× 375 1.8× 93 0.7× 135 1.2× 67 950
Jiří Mayer Czechia 11 748 2.0× 679 2.4× 162 0.8× 81 0.6× 320 2.7× 48 1.0k
S Eridani Italy 16 617 1.6× 477 1.7× 210 1.0× 129 0.9× 180 1.5× 71 1.0k

Countries citing papers authored by Paola R. Lev

Since Specialization
Citations

This map shows the geographic impact of Paola R. Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola R. Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola R. Lev more than expected).

Fields of papers citing papers by Paola R. Lev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola R. Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola R. Lev. The network helps show where Paola R. Lev may publish in the future.

Co-authorship network of co-authors of Paola R. Lev

This figure shows the co-authorship network connecting the top 25 collaborators of Paola R. Lev. A scholar is included among the top collaborators of Paola R. Lev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola R. Lev. Paola R. Lev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glembotsky, Ana C., Paola R. Lev, Cecilia P. Marín Oyarzún, et al.. (2023). Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus. Immunobiology. 229(1). 152782–152782. 4 indexed citations
2.
Goette, Nora P., Norma Alejandra Chasseing, Mónica A. Costas, et al.. (2022). Megakaryocyte–stromal cell interactions: Effect on megakaryocyte proliferation, proplatelet production, and survival. Experimental Hematology. 107. 24–37. 4 indexed citations
3.
Lev, Paola R., Nora P. Goette, & Rosana F. Marta. (2020). Pathophysiological Mechanisms Leading to Low Platelet Count in Immune Thrombocytopenia. 4(2). 1–7. 3 indexed citations
4.
Glembotsky, Ana C., Paola R. Lev, Cecilia P. Marín Oyarzún, et al.. (2016). Differential expression of SDF-1 receptor CXCR4 in molecularly defined forms of inherited thrombocytopenias. Platelets. 28(6). 602–606. 5 indexed citations
5.
Oyarzún, Cecilia P. Marín, Agostina Carestia, Paola R. Lev, et al.. (2016). Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms. Scientific Reports. 6(1). 38738–38738. 58 indexed citations
6.
Glembotsky, Ana C., Paola R. Lev, Nora P. Goette, et al.. (2015). Anagrelide platelet‐lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms. Journal of Thrombosis and Haemostasis. 13(4). 631–642. 25 indexed citations
7.
Goette, Nora P., Marina Gutiérrez, Ana C. Glembotsky, et al.. (2015). Long‐term follow‐up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status. European Journal Of Haematology. 96(4). 435–442. 16 indexed citations
8.
Glembotsky, Ana C., Nora P. Goette, Paola R. Lev, et al.. (2014). Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment. Blood. 124(21). 2792–2792. 2 indexed citations
9.
Lev, Paola R., Nora P. Goette, Ana C. Glembotsky, et al.. (2014). Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count. British Journal of Haematology. 165(6). 854–864. 40 indexed citations
10.
Goette, Nora P., Paola R. Lev, Paula G. Heller, et al.. (2010). Monocyte IL-2Rα expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms. Cytokine. 51(1). 67–72. 14 indexed citations
11.
Lev, Paola R., Nora P. Goette, Ana C. Glembotsky, et al.. (2010). Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis. Platelets. 22(1). 26–36. 20 indexed citations
12.
Goette, Nora P., Paola R. Lev, Paula G. Heller, et al.. (2010). Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia. Experimental Hematology. 38(10). 868–876.e1. 4 indexed citations
13.
14.
Goette, Nora P., Paola R. Lev, Paula G. Heller, et al.. (2008). Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia. British Journal of Haematology. 144(1). 69–77. 19 indexed citations
15.
Parekh, Samir, José M. Polo, Rita Shaknovich, et al.. (2007). BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood. 110(6). 2067–2074. 105 indexed citations
16.
Lev, Paola R., et al.. (2007). Platelets possess functional TGF-β receptors and Smad2 protein. Platelets. 18(1). 35–42. 24 indexed citations
17.
Lev, Paola R., Laura Kornblihtt, Carlos J. Pirola, et al.. (2005). PDGF-A, PDGF-B, TGF?, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide. American Journal of Hematology. 78(2). 155–157. 10 indexed citations
18.
Lev, Paola R., et al.. (2002). Variation of PDGF, TGFβ, and bFGF levels in essential thrombocythemia patients treated with anagrelide. American Journal of Hematology. 70(2). 85–91. 34 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana C. Glembotsky Breakdown of academic impact, for papers by Gerlinde Mitterbauer‐Hohendanner Breakdown of academic impact, for papers by Carmelo Gurnari Breakdown of academic impact, for papers by Jean Michel Cayuela Breakdown of academic impact, for papers by Serena Merante Breakdown of academic impact, for papers by Maria Kleppe Breakdown of academic impact, for papers by Christina A. Ortmann Breakdown of academic impact, for papers by Nicolas Duployez Breakdown of academic impact, for papers by Jiří Mayer Breakdown of academic impact, for papers by S Eridani
Rankless by CCL
2026